As #hemophilia treatments become more sophisticated, understanding the role of the dysfunctional F9 variant becomes more important:
Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated www.jthjournal.org/article/S153...
jthjournal.org
Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates
Factor IX (FIX) exhibits significant extravascular distribution and binds type IV
collagen in the subendothelial extracellular matrix in the extravascular space, which
influences its function and phar...